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Abstract 
Introduction 
 Diabetes is a proposed cause of dementia and age-related cognitive decline.  While the 
effects of hyperglycemia, insulin resistance, and hyperinsulinemia are well-known, scholarship 
tends to neglect distinct but related pathologies, such as chronic stress.  The purpose of this study 
is to evaluate whether a common proxy- mid-life involuntary job loss- is associated with reduced 
cognitive function among a cohort of diabetics.  A second objective was to determine if age of 
diabetes onset moderates this relationship.      
Methods 
 This cross-sectional study gathered diabetes data from the 2003 Health and Retirement 
Study (HRS) Mail Survey on Diabetes, while measures of cognitive function (HRS-Cog) and 
socio-demographic variables were assessed in the 2002 and 2004 HRS waves.  Multivariate 
regression was used to analyze the impact of job loss on cognitive function between 1992 and 
2002 among 153 job losers and keepers with complete data for employment history, the 35-point 
HRS-Cog, age of diagnosis, and glycemic control (HbA1c). 
Results 
 Job losers scored 1.52 points (-3.28-0.24, p<0.09) below keepers in the best fit model, 
adjusted for age of onset (<=55, >55) HbA1c quartiles, sex, education, hypertension, and 
retinopathy.  Age of onset did not moderate the association between job loss and cognitive 
function (β = -2.15, CI: -3.89- -0.40; p=0.016); sex, however, was solely responsible for the 
reversed, non-significant association in model two (β = -0.37, CI: -2.17-1.43; p=0.687).  
Adjustment for all covariates eliminated the significance of the job loss differential, as well as 
the effect of onset.  Retinopathy, education, and sex remained significant across all adjustments.  
Finally, the significance of job loss and onset was independent of each other and their magnitude 
comparable across most adjustments.  
Discussion 
 The relationship of involuntary mid-life job loss to cognitive function may reflect the 
myriad effects of chronic stress.  Even after controlling for well-established predictors of   
cognitive decline, the impact of job loss was comparable to the timing of diagnosis.  Because the 
significance of these two variables, as well as retinopathy, remained when modeled 
simultaneously, the effects of stress may involve unique and systemic pathways.  Furthermore, 
despite strong moderating effects from gender, the magnitude of the coefficient on job loss and 
the relatively young cohort are evidence for the hypothesis of premature aging.  This study 
demonstrates that appropriate interventions may benefit high-risk groups such as those with type 
II diabetes and that cortisol could be a viable co-factor related to cognitive function.    
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Introduction 
A unique set of pathologies links type II diabetes (DM) to dementia and age-related 
cognitive decline (ARD).  Insulin resistance and hyperglycemia, a common cause of vascular 
disease, share the same molecular basis with the formation of the neurotoxic beta-amyloid 
protein, and with neurofibrillary tangles, the pathological hallmarks of Alzheimer’s disease (AD) 
(Dore et al., 1997; Luchsinger, 2001).  The greater hippocampal and cortical atrophy observed in 
AD patients with DM compared to non-diabetic age-matched controls, however, was found 
independent of vascular disease and glycemic status, suggesting the importance of variations in 
insulin resistance (den Heijer et al., 2003).  The pro-survival PI3K-PKB insulin signaling 
pathway delays neuronal death and, when unresponsive, may accelerate the transport of toxins 
across the blood-brain barrier (Cole et al., 2006).  Among the pathologies that affect this 
pathway, chronic stress is unique, since glucocorticoids also alter the function of monocytes that 
inhibit beta-amyloid (Cukierman et al., 2005).  The current study, therefore, aims to determine 
whether stress is a viable candidate to explain the dramatic course of cognitive decline found in 
DM.  
Diabetes and Dementia 
A disease of impaired glucose metabolism, DM is estimated to increase risk for cognitive 
impairment roughly two-fold (Duron & Hanon, 2008).  While research supports a generalized 
cardiovascular complex, including systolic hypertension, high serum cholesterol, and 
atherosclerosis, diabetes is a global epidemic that entails distinct pathology (Korf et al., 2006).  
The anticipated “aging of the population” warrants examination of factors such as stress that 
potentially change the pathogenic relationship between DM and dementia.  Estimates, for 
instance, show that the 65 and older U.S. population will have increased from 18 percent in 2000 
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to twenty in 2030, and then finally to 1 out of 4 by 2070 (D.R. Williams, 1997).  The 
consequences of these figures to public health and health care in general are evident: the 
prevalence of DM and dementia will increase sharply through late adulthood (NHANES, 2011).  
Treatment and care for dementia currently exceeds $600 billion worldwide, or 1 percent of 
global gross domestic product.  DM prevalence in 2010 was approximately 8 percent in the 
general population but 26.9% among those 65 and older- a 100-fold difference compared to the 
0.26 percent of those 20 or younger (ADA, 2011)!  Importantly, DM could explain a significant 
proportion of the expected rise in dementia cases from 40 million today to 115 million by 2050 
(ADI, 2010).   Therefore, one of the most effective ways to inform national aging policy and 
public health preventions is to identify specific DM processes and their relation to ARD. 
Diabetes, Stress, and Aging        
Though hyperglycemia exposes the brain to higher concentrations of AD-related toxins, 
the latter are still found in the brains of middle-aged diabetics who show no signs of cognitive 
impairment or neurodegeneration (Li et al., 2005).  This limitation is illuminating, since high 
blood glucose coincides with elevated levels of neurotoxic proteins and enhanced permeability 
within the vasculature itself (Abbott et al., 1990).  Moreover, macrovascular (cerebral infarction, 
peripheral arterial disease) and microvascular (lacunar infarction, arterioscelerosis) lesion 
pathology is associated with amyloid deposition in vivo, as well as with higher rates of oxidative 
stress independently of hyperglycemia (Whitehead et al., 2005; Oddo et al., 2003).  These 
findings imply that a “second hit” may be necessary to induce neurodegeneration and associated 
cognitive impairment.   
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An alternative explanation for glycemic status and vascular disease is insulin resistance 
proper.  While glucocorticoids (primarily cortisol) exacerbate the poor use of insulin, a sizeable 
number of DM patients may suffer from the withdrawal of cellular signaling that normally 
protects neurons from a range of insults (Biessels et al., 2006).  Equally important is the 
observation that defects to the insulin-mediated pro-survival pathway overlap with the 
processing of amyloid-beta and neurofibrillary tangles (Lester-Coll et al., 2006).  Though 
hyperglycemia and hyperinsulinemia facilitate the movement of these toxins across the brain 
parenchyma, extreme insulin resistance may be more detrimental, as growth factor resistance and 
plasticity could decline, and protein synthesis accelerate even further (Salkovic-Petrisic, 2006).  
Within this causal milieu, cortisol can introduce comparable actions; conversely, cortisol could 
interfere with lymphocyte- and monocyte-mediated detoxification (Whitmer, 2007; Sapolsky, 
1999).  Finally, it is possible for insulin-mediated growth factor production to remain intact, but 
for damaged macrophages and Schwann cells to extract insufficient trophic hormone for cellular 
regeneration (George et al., 1995; Chaudry & Cornblath, 1992).  In other words, the cellular 
regenerative process could remain at least partly functional when insulin-related growth factors 
do not (Lucas et al., 2001; Stoll & Muller, 1999).  Collectively, these outcomes may be more 
predictive of memory and learning deficits than the similarly diverse effects of hyperglycemia 
and hyperinsulinemia.   
In summary, a significant body of evidence justifies the analysis of stress as a unique and 
independent etiological agent on the pathway from exposure (DM) to disease (dementia).  In 
addition, observational and psychological studies note lower working memory scores for DM 
patients and for subjects with a self-reported history of distress (Lupien et al., 1998).  Despite the 
fact that mid-life stress is already a well-established contributor to vascular disease from stroke 
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to hypertension- conditions already known to affect cognition- few studies have examined 
whether major adverse events interact with critical markers of chronic disease pathology, such as 
glycemic control (Hipple, 1999; Turner, 1995; Brenner, 1997; Matoba et al., 2003).  As the most 
common neurodegenerative disorder, AD is indeed often described as a neuroendocrine disorder, 
as well as a disease of impaired clearance (McDonald et al., 2010; Fontbonne et al., 2001). 
Stress and Job Loss 
  The current study uses middle or late life involuntary job loss as a proxy for chronic 
stress.  This adverse event is a well-established source of chronic psychosocial adversity (Gallo 
et al., 2004), and often precedes income, health insurance, and pension severance, as well as 
termination of social support in the workplace and uncertainty of reemployment (Chan & 
Stevens, 2001; Fallick, 1996).  These changes often coincide with lowered perceived behavioral 
control (Goodman, 2003) and substance abuse (Price et al., 2000).  (The former is associated 
with higher cortisol even when controlling for genetic and environmental factors.)  Within the 
present context, involuntary job loss follows plant, business, or factory closure, and financial or 
operational downsizing.  Iversen (1989), for instance, found shipyard workers were at higher risk 
for cardiovascular hospital admission after their worksite closed.  More recently, Gallo & 
colleagues (2006) linked late-career job loss with a greater than two-fold increase in both 
myocardial infarction (HR: 2.48; 95% CI: 1.49-4.14) and stroke (HR: 2.43; 95% CI: 1.18-4.98).  
As several authors note, both the psychological and physical aspects of involuntary job loss 
reflect health outcomes associated with chronicity rather than with the buildup of daily hassles or 
acute challengers (Kirschbaum & Hellhammer, 1994).  These results indicate, at the least, a face 
valid proxy.   
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The specific objective of this study was to evaluate the association between middle- or 
late-life involuntary job loss and performance on a telephone-administered test of cognitive 
function among a nationally representative sample of diabetics.  The main hypothesis was that 
job losers would score significantly lower than keepers.  As the most comprehensive population-
based longitudinal study on health and aging in the United States, the Health and Retirement 
Study (HRS) is currently the only dataset that samples sufficient numbers of older diabetics, as 
well as collects extensive information on employment history, physical health, and cognitive 
performance.   
 A second objective was to test the hypothesis that age of onset moderates the relationship 
between employment status and cognitive performance.  Specifically, it was speculated that a 
variable for the timing of DM diagnosis would capture extreme insulin resistance adequately 
enough to reduce the job loss coefficient, and that this effect would exist regardless of glycemic 
control.  As previously mentioned, research has shown that severe insulin resistance is sufficient 
to cause death to a diversity of neurons, and, as importantly, that age of onset may reflect this 
pathology even when controlling for DM duration (Falkingham & Namazie, 2002).  Recent 
studies have also found timing a more significant predictor of cognitive impairment than a 
diagnosis alone (Breitling et al., 2012).  That is, upon adjustment, differences on COGTEL 
scores (an instrument similar to HRS-Cog) virtually disappeared between those with and without 
DM.       
Methods 
Study Design and Data 
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 This cross-sectional study gathered data for diabetes-related variables from the 2003 HRS 
Mail Survey on Diabetes, while scores on the 35-point HRS cognitive measure (HRS-cog) were 
collected in 2002 as part of the HRS Cognition Imputations (1992-2008).  The Health and 
Retirement Study is a nationally representative longitudinal cohort study that samples over 
20,000 adults aged 51 years and older biennially.  It is administered through the Institute for 
Social Research at The University of Michigan and funded federally by the National Institute for 
Aging.  The objective of the Mail Survey on Diabetes was to gather self-reported questionnaire 
data on factors relevant to treatment and self-management, as well as to collect a marker of 
glycosylated hemoglobin (HbA1c) for measuring blood glucose control.  Study instruments were 
validated at the Michigan Diabetes Research and Training Center, while HbA1c was assayed by 
Flexisite Diagnostics, Inc.  A detailed description of the sampling methodology of both surveys 
is available elsewhere (HRS, 2003).  
 The sample criteria for the current study required that participants meet all of the 
following conditions: a self-reported diagnosis of diabetes in the 2002 HRS wave; complete 
information from the 2003 HRS Mail Survey on Diabetes for age of diagnosis and HbA1c; 
complete data for employment history from 1992 to 2002; and complete scores on the 2002 
cognitive assessment from the HRS Cognition Imputations (1992-2008).   
A total of 3,194 respondents reported diabetes in the 2002 wave.  From this group 2,385 
participants were deemed eligible at the start of the 2003 Diabetes Survey, after which 1,901 
mail surveys were returned (79.7 % response rate) and used for analysis.  Because the 2003 
participants were required first to self-report diabetes in 2002, incident cases between 
assessments were automatically excluded.  This allowed self-reported diabetes to be evaluated as 
a precedent of cognitive performance in 2002.   
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 Access to the 2003 HRS Mail Survey on Diabetes was approved by the Behavioral 
Sciences Committee institutional review board at the University of Michigan, while the 2002 
HRS wave is available freely to the public.  Respondents for both surveys were linked by unique 
household and personal identifiers that maintain anonymity.           
Primary independent variables 
 All participants who self-reported diabetes in the 2002 HRS Core and returned the 2003 
Survey were eligible for analysis.  From the 1,901 participants who returned mail surveys, 1,180 
had complete data for age of diagnosis, HbA1c, and employment status.  The HRS Core has a 
distinct section for job history, including reasons for leaving and changing employers.  As a 
binary indicator, involuntary job loss was defined as a self-reported plant, factory, or business 
layoff between the HRS 1992 baseline and the 2002 follow-up.  As the calendar year is not 
recorded for job loss prior to 1992, the exclusion of prevalent events effectively reduced the bias 
of including those from early and middle adulthood.  However, this also resulted in the removal 
of potential prevalent late life events among older members of the sample.  Since the vast 
majority of elders (65+) were retired at baseline, and thus ineligible for analysis, and because the 
final sample was limited almost entirely to those who were between 51 and 57 in 1992, this bias 
is likely insubstantial.   
Participants were considered “exposed” and included in the job loss/stress group had they 
reported employment at baseline, followed by job loss at any of the subsequent five waves.  
These respondents were also required to have self-reported involuntary job loss at the 2002 HRS 
wave, thereby assuring they were truly exposed when the dependent measures were obtained.  
The HRS uses a particular question to assess the cause of unemployment among those who cite 
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disruption in their work lives: “Did the business close, were you laid off or let go, did you leave 
to take care of family members, or what?”  The present study distinguished those whose sole 
response was “laid off/let go” from those who attested either to voluntary transition (i.e. on 
temporary leave, resignation for a better job, retired, etc.) or to departure for medical or personal 
reasons (i.e. disability or family crisis).  The job loss group further excluded the self-employed 
and the re-employed following loss.  However, anyone who began working for a new employer 
during the 10-year period and who later selected “laid off/let go” was also included.  
 The comparison group included only respondents employed at baseline and at each 
subsequent wave up to 2002.  (This was considered an effective way to avoid “the healthy 
worker effect.”)   The comparison included job changers and those on temporary leave.  
Individuals, however, were excluded had they reported retirement, self-employment, or departure 
on account of illness or disability, regardless of future job gain.  Reporting events before 1992 
was also grounds for disqualification.  Since access to medical care might have differed across 
employer, insurance status at the time of diagnosis and at the 2002 wave was assessed.  An 
indicator variable was then created comparing those with insurance at both times to those 
without.           
 Although the sample was expected to have varying times of diagnoses (both before and 
after the event), limiting the exposed to a single temporal sequence might have produced 
insufficient counts.  The overwhelming majority (> 90 %), however, reported diagnoses prior to 
job loss, thus enabling interpretation of how a significant chronic stressor might alter the vector 
of an existing condition of self-reported DM.  Because the objective was to evaluate the effects 
of a stressful event on the diabetic process in general, self-reporting “laid off/let go” before or 
after diagnosis remained the inclusion criterion.  Moreover, to differentiate job loss that reflected 
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the worsening of chronic disease, participants were excluded if they regarded their illness as a 
source of occupational challenge.    
Glycemic control was measured with an HbA1c Home Test Kit.  Of the 1,901 returned 
surveys, a total of 1,233 valid blood samples were obtained, yielding a response rate of 64.9 
percent.  Quartiles (< 6.3, 6.4-6.9, 7.0-.7.8, > 7.8 mg/dL) were constructed to characterize the 
sample’s measurements, where the highest range was associated with hyperglycemia, and the 
lowest hypoglycemia.               
Model Covariates 
 Adjustment variables and potential confounders were chosen for their strength of 
association with cognitive function in the literature, as well as for their bivariate relationship 
within the sample itself.  Socio-demographic data was derived from the 2002 HRS and included 
age, education, sex, and health insurance.  Income was derived from the 2002 Core Income and 
Wealth Imputations, and comprised all earnings, including labor and investment income, as well 
as pension accrual.  The small number of occupation codes rendered the job class distinction 
unfeasible.  However, prior analysis and imputations with this sample and others show that sex, 
net earnings, and education are more significant predictors of test scores (Fisher et al., 2012 ), 
while blue-collar occupation in the HRS is relatively low (< 30 %) as a whole (Gallo et. al, 
2006).  Smoking status (never [ref], former, current) was collected in 2002, as well as the self-
reported presence of hypertension, high cholesterol, congestive heart failure (CHF), retinopathy, 
and stroke or transient ischemic attack (TIA).  Participants were asked specifically, “Has a doctor 
ever diagnosed you with [condition]?”  Lastly, the Diabetes Survey gathered information on use 
of insulin and oral hypoglycemic medication.  
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Primary outcome variable 
 Cognitive function was evaluated on a 35-point scale (HRS-Cog) modeled after the 
Telephone Interview for Cognitive Status (TICS), a population-based instrument closely 
resembling the Mini-Mental Status Examination (MMSE).  The HRS-Cog is part of the HRS 
Cognition Imputations (1992-2008), which consist of immediate and delayed recall tests; a 
backwards-count from 20 test; a common knowledge test to measure orientation; and a serial-7 
subtraction task to measure working memory.  Research has shown this test to predict several 
outcomes, including greater likelihood of nursing home admission (Banaszak-Holl et al., 2004). 
Because these tests were conducted biennially, a sensitivity analysis was also performed with 
HRS-Cog data from the 2004 wave.  This supplementary analysis was considered appropriate, as 
some variables (e.g. HbA1c) were gathered after 2002, even though meaningful change is 
unlikely between successive years (Albright et al., 2001).   
Data Analysis 
 The sample is described by means and standard deviations for continuous variables and 
frequencies for categorical.  Multivariate regression was used to assess the relationship between 
job loss and cognitive function.  The unadjusted model in Table 3 included the independent 
effects of the three primary study variables, including age of diagnosis and HbA1c quartile.  The 
partially adjusted model 2 was further corrected for age, education, sex, diabetes medication, 
income, and insurance.  Finally, the fully adjusted model comprised smoking and established 
vascular risks, where factors achieving a specified significance (< 0.20) were initially included 
but later removed (< 0.15).  Variables that altered the coefficient on job loss by greater than 10 
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percent were retained in the fully adjusted models from both tables.  All analyses were conducted 
in SAS 9.2.                 
Results 
Characteristics of the Sample 
 A total of 1,180 participants had complete information for employment history, age of 
onset, and HbA1c levels.  Subsequently, forty-one reported work at baseline followed by 
involuntary loss and 212 stated continuous employment from 1992-2002.  The majority of the 
remaining 927 were retired, but a few were disabled, self-employed, or on temporary leave.  The 
characteristics of the sample are shown in table one.  Job losers were slightly older (63.5 v. 61.8, 
respectively) than their counterparts at the time of assessment, while both groups were 
significantly younger than the diabetic sample as a whole.  The comparison group was more 
likely to be female (39.7 % v. 23.1 %), to be insured (89.2 % v. 76.3 %), to use oral diabetes 
medication (72.2 % v. 51.9 %), and to have hypercholesterolemia (69.6% v. 55.0 %).  Job losers 
had significantly higher HbA1c readings (7.7 v. 7.2), an earlier age of onset (50.4 v. 52.9), as well 
as a higher prevalence of current or former smoking (70.0 % v. 60.7 %).  Over half the comparison 
group had obtained a college degree or more, while job losers were more likely to have a high 
school degree or less (58.6 % v. 50.0 %), even though a greater percentage lay above the $14,250 
median for income (53.7 % v. 36.8 %).   
 From the 253 participants who met the criteria for inclusion into either the job loss group 
or the comparison, 153 had complete scores on the HRS-Cog.  Five of the 41 job losers and 
ninety-five of the controls did not complete the cognitive assessment.  The 100 excluded were 
more likely to be younger (M = 59.9 + 8.2), to have an earlier age of onset (M = 50.4 + 13.9), and 
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to have hypertension (74 %).  The five excluded job losers were no more likely than the 95 
keepers to have a diagnosis above or below the median (X
2
 = 0.251, p=0.635).                    
Association with Cognitive Performance 
Job losers scored roughly two points below the comparison in the unadjusted analysis 
(22.8 v. 24.9, p <.017).  A similar differential surfaced between those diagnosed before and after 
age fifty-five (25.5 v. 23.6, p <.014).  Neither the scores of the highest HbA1c quartile nor the 
intermediary quartiles were significantly better than those of the lowest, while a college degree 
or more conferred a clear advantage, as performance was over five points higher compared to 
reference (26.2 v. 21.0, p<.001).  Higher income (> $14,500) was also beneficial (25.1 v. 23.3, p 
<.130), and females tended to score higher than males (25.5 v. 24.1, p <0.001).  Diabetics who had 
never smoked (25.6 v. 24.0, p=0.210), and who had hypertension (24.9 v. 23.6, p <.110) or high 
cholesterol (24.9 v. 23.8, p <0.200) fared superiorly, though these differences did not reach 
significance.   
Table 3 shows that job loss ceased to be significant within the partially adjusted model 
two.  Sex alone accounted for this effect, while education (p<.0001) remained the most significant 
predictor.  The fully adjusted model three recovered this association moderately (-1.18, p = 0.231), 
where changes to the coefficient were most noticeable upon the inclusion of retinopathy (-3.00, p 
<0.027).  When HbA1c was added, the lowest quartile (< 6.3) was clearly associated with the 
poorest function, whereas the second (6.4-6.9) the highest (1.63, p <0.098).   
The best fit models from table 4 indicate that neither onset nor glycemic control 
moderated the primary study relationship.  In fact, the second model demonstrates that job loss 
became more robust (-2.32, p=0.013).  The final model relates this loss to a 1.5 point decrement (-
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3.28-0.24, p <0.09), or roughly equivalent to the effect of gender (-1.42, p<0.05).  The highest level 
of education (5.34, p<0.001) and retinopathy (-2.25, p<0.063) were again the most significant.  
When sex was removed, the magnitude of unemployment peaked (-2.71, p<0.003). 
Closer analysis revealed no sex difference among the exposed (23.7 v. 23.6, p = 0.990) but 
a marginally significant protective effect for females within the comparison (24.5 v. 25.7, p 
<.095).        
Sensitivity Analysis 
 Repeated analyses were conducted with data from the HRS 2004 Wave of Cognitive 
Imputations.  Though the sample size was smaller, scores were still significantly higher (24.8 v. 
22.8, p<.056) among job keepers.  Age of onset was also a significant determinant of cognition 
(24.9 v. 23.1, p<.041), while glycemic control was not (F = 1.13, 3, p=.343).  After adjusting for 
onset, the association between cognition and job loss declined slightly (-1.62, p=0.136), though 
sex again had the largest effect on the coefficient (0.41, p=.843).  After controlling for 
retinopathy, hypertension, high cholesterol, and smoking, job loss gained predictive power (-
2.46, p<0.036).  Age and education were the only other variables to alter the association 
appreciably.              
Discussion 
To the extent that abrupt and prolonged unemployment captures psychosocial stress, the 
current results have several interpretations.  A significant stressor was related to poorer cognition 
independent of age of onset and a clinical marker of glucose control.  This association persisted 
after adjustment for hypertension, high cholesterol, and retinopathy, all vascular processes that 
overlap with stress.  Research often cites delayed recovery from chronic disease, but elevated 
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cortisol has several effects: upregulation of pro-inflammatory cytokine signaling; increased 
susceptibility to acute infectious illness; and exacerbation of insulin resistance.  While this study 
is too limited to support a single pathway, the HRS-Cog differential is potentially robust enough 
to support the simple notion of a diabetes-stress complex.  This conclusion, however, obviously 
depends on whether the relatively small study sample captures the characteristics of the 
population at-large.  If this is the case, the results could reflect what has been described in the 
literature as “particular combinations of co-factors that activate different mechanisms of brain 
dysfunction and/or neurodegeneration,” as well as “a factor [stress] amplifying the same 
mechanism as another already present factor [e.g. insulin resistance] (McDonald et al., 2010).”  
In general, elevated cortisol may be one of several conditions that dramatically affect the 
pathogenic course of DM.       
Compared to diabetes patients stably employed, adult job losers scored roughly two 
points less on a validated measure of neuropsychological functioning, a gap that was slightly 
above the difference between  those with “early” and “late” onset.  Interestingly, a recent cross-
sectional analysis of Germans elders arrived at comparable results (Breitling et al., 2012).  In this 
work Germans diagnosed with diabetes before the age of 60 scored 2.76 points (-4.64-0.87, 
p<.005) below their counterparts.  This differential was later equated to roughly eight years of 
excessive aging, and deemed more predictive of cognitive function than a diagnosis alone.  The 
relatively young sample and limited age range makes it difficult to extrapolate within the present 
study; however, previous research has found HRS-Cog quartiles predictive of several adverse 
conditions, notably mortality (Mehta et al., 2003).  If the job loss differential were influential 
enough to displace an observation into an adjacent quartile, our understanding of the burden of 
stress could change appreciably.  This is a burden that is, of course, associated with early death 
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in many studies (Alwin, 2008).  Regardless, these results attest strongly to the “premature aging 
hypothesis,” since the differential persisted in the presence of a young cohort and the adjustment 
for chronic disease.   
Models one and two from table 4 imply that age of onset and glucose control might have 
been insensitive indexes of abnormality and that they failed collectively to mitigate the effects of 
job loss.  Diabetes timing, though, was still associated with reduced performance, and its effect 
independent of the primary exposure, as well as the demographic factors in model 2 from table 
three.  While onset was likely too broad to capture disease severity accurately, the interaction of 
job loss with DM may have been significant itself.  In support of this conclusion, neither 
insurance status nor income had discernible impact.  Complications arising from inaccessibility 
to medical care are therefore unlikely to have contributed meaningfully to the observed 
differences.   
Greater oxidative stress is one hypothetical effect of stress-induced job loss.  Still, this is 
an unlikely candidate, since onset and retinopathy were also statistically significant.  The 
significance of retinopathy, a marker for severe oxidation, does confirm recent work with a 
similar age group (Rosebud, 2008), but because the effect of the primary exposure was still 
independent of each factor, it is more likely to represent a distinct pathway, such as lowered 
synaptic plasticity.  Though both stress and retinopathy involve changes to the vasculature, the 
former may also elicit cytokines that impair the removal of toxins.  As we have seen, AD is often 
described as “a disease of impaired clearance.”   
Within the context of statistical modeling, crude distinctions such as time of onset and 
self-reported retinopathy (without regard to duration) may be too general to moderate the 
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systemic and manifold effects of stress.  The contributions of cortisol to brain function and 
memory impairment may also differ by time of onset within the stage of disease.  It may, for 
instance, play an important role in the early stages of ARD, particularly since amyloid 
accumulation, at its extreme, is unlikely to result from insulin resistance alone (Stewart & 
Liolitsa, 1999).  Future work should integrate descriptive clinical and epidemiological data to 
determine whether one pathway most strongly modifies the effect of proxies like job loss, 
leading to what appears here to be “advanced cognitive aging.”            
In the current analysis, the relationship among stress, diabetes, and cognitive aging 
depends on how one interprets the role of gender, which single-handedly reversed the primary 
coefficient.  This association effectively vanished, and the hypothesis that time of onset would 
moderate the relationship between stress and cognition nullified.  Interestingly, female sex was 
associated with higher performance among job keepers but not losers.  This finding belies what 
would otherwise be a tempting interpretation: current research shows that females tend to adapt 
differently- and more effectively- to adverse major life events (Belle, 1987).  Female sex in this 
sample, however, may reflect occupational variation, differential exposure to complex tasks, or 
simple biological difference.  If being female was related to less work strain, greater job 
complexity, or more autonomy within the workplace, selection bias could result.  (Obviously, 
bias could have existed differentially between losers and keepers.)  Thus the absence of relevant 
data on occupation and rank is the single most serious flaw that limits the generalizability of 
these results.  On the other hand, research with the same cohort has found sex, rather than job 
class, a protective influence on the incidence of both cerebrovascular disease and lacunar 
infarction (Gallo et al., 2004).  Future studies should also assess the prevalence and trajectory of 
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workplace learning and the performance of complex tasks, as well as how they impact each 
gender.                   
This is the first epidemiological evaluation of emerging laboratory and clinical evidence 
for the pathogenic role of chronic stress on diabetes-related cognitive function.  Strengths of the 
analysis include the use of a wide range of physiological measurements, the inclusion of a 
nationally representative sample of adult diabetics, and a relatively long period of observation 
(1992-2002).  While past studies have assessed the joint effect of blood cortisol levels and 
chronic disease, the current incorporated detailed data on many of the most relevant markers.  In 
addition, nearly all job losers were diagnosed before the event and excluded had they reported 
DM to have a negative career effects.  The removal of prevalent events at baseline eliminated the 
bias of including those from middle and early adulthood.  Lastly, the diversity of adjustment 
variables was comparable to past studies (Allen et al., 2004).   
Several limitations deserve notice.  The aforementioned failure to characterize the nature 
of both the workplace and the transitional environment was the most critical, even though prior 
studies differentiated only between blue- and white-collar occupations, and were less likely to 
incorporate characteristics relevant to the outcome (Gallo et al., 2000).  Secondly, recent HRS 
work has found lower cognitive scores among workers who retire early in life but also 
acknowledges that poor cognition leads to retirement (Rohwedder & Willis, 2010).  The 
potential for “reverse causality” is considerable, and controlling for this effect is challenging 
within the HRS.  Unlike most studies, however, age was insignificant.  This anomaly may reflect 
the younger sample age (compared to the entire HRS diabetes cohort) and the limited age range, 
as well as the exclusion of retirees.  The small percentage of nona- and octogenarians could have 
placed a ceiling on the significance of several exposures, notably onset and stroke.  Likewise, the 
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cognitive effects of an adverse midlife event could be insubstantial to older elders compared to 
the cumulative effects of chronic disease.  The prevalence of cerebrovascular disease was also 
relatively small for an adult sample of diabetics, and the low number of job losers was not 
representative of a group generally regarded at the very highest risk for ARD.  Finally, several 
variables would likely improve the best fit model from table 4 (adjusted-R
2 
= 0.317), including 
the duration and treatment of retinopathy, the nature of post-work social support, and the 
genotyping of APOE 4, the only known genetic risk factor for late-onset sporadic AD.      
The consequences of stress to brain structure and function are not transient.  Involuntary 
job loss shares characteristics with the most harmful stressors, specifically those that are novel, 
unpredictable, and uncontrollable.  Even though most societies have provisions for population 
change, these measures are undermined by recessions, mass layoffs, and financial hardship.  The 
risk of chronic disease is also greater for the roughly 2 million unemployed Americans over the 
age of fifty-five, a group that not only requires the longest time to regain employment but that 
expends greater energy to acquire the same set of skills (Rich, 2010).  Even though prevention 
commonly addresses ARD, few concern the stress response following a major event.  Recent 
research has even shown that high school students diagnosed with the disease are 10 percent less 
likely to find employment and can expect to lose an average of $160,000 in lifetime earnings 
(Fletcher & Richards, 2012).  It would not be surprising then for a diabetes-stress complex to 
gain even greater attention in the subsequent years.   
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List of Tables 
 
Table 1.  Description of the Eligible Sample by Involuntary Job Loss (n = 1,180)   
                                       All Diabetics             Job Loss        Non-Job Loss 
Characteristic                     N (%)*             N (%)*              N (%)*           
Age (years), mean + SD              68.6 + 8.7                63.5 + 7.8             61.8 + 6.9                      
Sex  
    Male                     330 (28.0)               20 (48.7)     73 (34.4) 
    Female                                                      289 (24.5)                     6 (14.6)               48 (22.6) 
Education  
    Less than high School                              354 (30.0)                    10 (24.4)     40 (18.9) 
    High School                                              402 (34.1)                    14 (34.2)     66 (31.1) 
    Some college         213 (18.1)    11 (26.8)              44 (20.8) 
    College or more                    211 (17.9)      6 (14.6)      62 (29.3) 
Age of onset (years), mean + SD                57.6 + 13.5               50.4 + 13.8           52.9 + 11.9            
HbA1c, mean + SD                                         7.2 + 1.4      7.7 + 1.4                7.2 + 1.5 
Insurance 
     Yes          986 (83.6)     29 (70.7)            181 (85.4) 
     No          146 (12.4)       9 (21.9)              22 (10.4) 
Income   
  > 14,250 (US $)                   316 (26.8)                   22 (53.7)             78 (36.8)  
  < 14,250 (US $)                                         864 (73.2)                     19 (46.3)            134 (63.2) 
Insulin use 
     Yes          273 (23.1)        9 (22.0)               40 (18.9) 
     No          879 (74.5)      32 (78.0)             170 (80.2) 
Oral diabetes medication use 
     Yes          854 (72.4)      31 (51.9)      148 (70.0) 
     No          291 (24.7)      10 (48.1)        57 (26.9) 
Smoking history 
     Never          234 (19.8)        9 (22.0)        48 (22.6) 
     Former                      259 (22.0)      12 (29.3)               51 (24.1) 
     Current          134 (11.4)        9 (22.0)         23 (10.8) 
Stroke or transient ischemic attack 
     Yes               64 (5.4)          0 (0.0)             5 (2.4) 
     No        1,073 (90.9)      40 (97.6)       204 (96.2) 
Hypertension 
     Yes                       869 (73.6)      27 (65.9)       145 (68.4) 
     No           284 (24.1)      14 (34.1)         60 (28.3)  
High Cholesterol 
     Yes                       711 (60.3)     22 (53.7)       142 (67.0) 
     No           420 (35.6)     18 (43.9)         62 (29.2)  
Retinopathy 
     Yes          155 (13.1)       5 (12.2)           20 (9.4) 
     No          964 (81.7)     32 (78.0)       182 (85.8) 
Congestive Heart Failure 
     Yes                      138 (11.7)         3 (7.3)             7 (3.3) 
     No          999 (84.7)                      37(90.2)       202 (95.3)   
 
* Numbers may not sum to 1,180 due to missing data, and percentages may not sum to 100% due to missing data. 
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Table 2.  Mean (95 % confidence intervals) HRS-Cog Scores for Keepers and Losers by Study Characteristic (n = 153)  
             
Characteristic                              N*                    Total Score                           p
†
 
Job Loss                     <0.017 
    Yes                                            36       22.8   (20.4-25.1)                             
    No                                                      117                   24.9   (24.2-25.6)                             
Age of onset (years)                    <0.014 
    < 55                            84                            23.6   (22.4-24.8)      
    >55                69       25.5   (24.7-26.3)      
HbA1c (quartiles)         <0.540 
    < 6.3                38       24.0   (22.8-25.1)      
   6.4-6.9               44                   25.3   (24.0-26.7)      
   7.0-7.8               35                   24.2   (22.7-25.7)      
    > 7.8                36                            24.1   (21.9-26.3)   
Age     
    51-59               23                            23.4   (20.1-26.7)                    <0.052 
    60-69             110                   25.0   (24.2-25.8)      
    70+                            20                   22.5   (21.0-24.0)      
Sex  
    Male                88                           24.1   (23.5-25.3)                        0.127                                                   
     Female                                                53                           25.5   (24.3-26.7)                                                                
Education             <0.001 
    Less than high School                         37                           21.0   (19.6-22.4)           
    High School                                        50                           24.7   (23.3-26.0)       
    Some college                           30       26.2   (24.5-27.9)      
    College or more              36       26.2   (24.8-27.5)  
Income (US $)                                                                                                                            0.021 
  > 14,250               96                  25.1   (24.2-26.0) 
  < 14,250                                                57                       23.3   (21.9-24.6) 
Insulin use              0.351 
     Yes                26                           25.2   (23.7-26.7)       
     No              127                  24.3   (23.4-25.1)                    
Oral diabetes medication use           <0.650 
     Yes                          115                           24.6   (23.6-25.5)       
     No                36                           24.1   (22.8-25.4)       
Smoking history              0.210 
     Never               54                           25.6   (24.5-26.8)       
     Former               61                           24.5   (23.6-25.5)       
     Current               30                           24.0   (21.9-26.1)       
Hypertension              <0.110 
     Yes                98                 24.9   (24.0-25.9)                
     No                51                 23.6   (22.1-25.1)        
High Cholesterol 
     Yes                96                 24.9   (23.9-25.8)                        <0.200 
     No                51                 23.8   (22.4-25.2)         
Retinopathy 
     Yes                13                 23.7   (20.7-26.6)                        <0.520 
     No                133                 24.6   (23.8-25.4)        
              
* Numbers may not sum to 153 due to missing data. 
† P-value is for pooled equality of variances test (continuous variable). 
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Table 3.  Multiple linear regression models predicting total HRS-Cog scores by 3 primary study variables (n = 153)  
 
                                                         Model 1
a
             Model 2
b
                       Model 3
c 
              
Predictor                     Unadjusted β                   p                        Adjusted β                     p                    Adjusted β                   p          
   
                   (95 % Confidence Interval)
                          
(95 % Confidence Interval)
                    
(95 % Confidence Interval)
                                 
 
Involuntary Job Loss          
    No                                    Reference                    ---              Reference                   ---                 Reference                   --- 
    Yes                                       -2.16 (-3.93- -0.39)           0.017            -0.37 (-2.17-1.43)            0.687        -1.18 (-3.12-0.76)            0.231                                              
Age of onset (years)  
    > 55             Reference                    ---                     Reference                   ---                 Reference                    ---  
    < 55                 -1.91 (-3.42-0.40)         0.014            -1.39 (-2.89-0.10)            0.067       -0.88 (-2.51-0.76)             0.290                                 
HbA1c (quartiles)          
    < 6.3                       Reference           ---            Reference           ---                 Reference                   --- 
    6.4-6.9        1.34 (0.08-2.29)         0.207             1.23 (-0.62-3.08)             0.191       1.54 (-0.40-3.49)             0.118     
    7.0-7.8                   0.23 (0.05-2.58)         0.841             1.05 (-0.94-3.02)             0.298       1.08 (-0.96-3.11)             0.297   
    > 7.8                   0.08 (-1.98-0.29)         0.942             1.05 (-1.02-3.13)             0.317       1.71 (-0.53-3.96)             0.138  
                   
a
 Unadjusted with individual effects of the three predictors.  
b
 Adjusted for age, sex, education, income, insurance, insulin, and oral diabetes medication. 
c
 Adjusted for age, sex, education, income, insurance, insulin, oral diabetes medication, smoking history (never, former, current), 
hypertension, high cholesterol, and retinopathy. 
  
25 
 
Table 4.  Best fit multiple linear regression models predicting total HRS-Cog scores by involuntary job loss (n = 153)  
 
                                                         Model 1
a
               Model 2
b
       Model 3
c   
R
2 
= 0.317 
              
Predictor                     Adjusted β                  p                            Adjusted β                   p                      Adjusted β                 p                  
   
                (95 % Confidence Interval)
                           
(95 % Confidence Interval)
                    
 (95 % Confidence Interval)
                                 
 
Involuntary Job Loss          
    No                               Reference                    ---                      Reference                     ---                Reference                       --- 
    Yes                                    -2.15 (-3.89- -0.40)         0.016              -2.32 (-4.15- -0.49)          0.013          -1.52 (-3.28- 0. 24)     <0.09                                                           
                   
a
 Adjusted for age of onset. 
b
 Adjusted for age of onset and HbA1c quartiles. 
c
 Best fit model.  Adjusted for age of onset, HbA1c quartiles, sex, education, hypertension and retinopathy. 
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